Discovery of Small-Molecule Autophagy Inhibitors by Disrupting the Protein–Protein Interactions Involving Autophagy-Related 5
Journal of Medicinal Chemistry · 23.02.2023 · 66 (4) · 2457-2476
DOI: 10.1021/acs.jmedchem.2c01233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 07.02.2023. Verfasst von Honggang Xiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai 201203, People's Republic of China. Hauptthemen laut MEDLINE: Autophagy, Autophagy-Related Protein 12, Autophagy-Related Protein 5, Autophagy-Related Proteins. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
One possible strategy for modulating autophagy is to disrupt the critical protein-protein interactions (PPIs) formed during this process. Our attention is on the autophagy-related 12 (ATG12)-autophagy-related 5 (ATG5)-autophagy-related 16-like 1 (ATG16L1) heterotrimer complex, which is responsible for ATG8 translocation from ATG3 to phosphatidylethanolamine. In this work, we discovered a compound with an (E)-3-(2-furanylmethylene)-2-pyrrolidinone core moiety (T1742) that blocked the ATG5-ATG16L1 and ATG5-TECAIR interactions in the in vitro binding assay (IC50 = 1-2 μM) and also exhibited autophagy inhibition in cellular assays. The possible binding mode of T1742 to ATG5 was predicted through molecular modeling, and a batch of derivatives sharing essentially the same core moiety were synthesized and tested. The outcomes of the in vitro binding assay and the flow cytometry assay of those newly synthesized compounds were generally consistent. This work has validated our central hypothesis that small-molecule inhibitors of the PPIs involving ATG5 can tune down autophagy effectively, and their pharmaceutical potential may be further explored.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai 201203, People's Republic of China.
- School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China.
- Department of Chemistry, Shanghai Normal University, 100 Guilin Road, Shanghai 200234, China.
- State Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, People's Republic of China.
ORCID-Profile: Lu Zhou, Yingxia Li, Renxiao Wang
Förderung
- Ministry of Science and Technology of the People's Republic of China
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
Zitieren
APA
Xiang, H., Liu, R., Zhang, X., An, R., Zhou, M., Tan, C., Li, Q., Su, M., Guo, C., Zhou, L., Li, Y., & Wang, R. (2023). Discovery of Small-Molecule Autophagy Inhibitors by Disrupting the Protein–Protein Interactions Involving Autophagy-Related 5. Journal of Medicinal Chemistry, 66(4), 2457-2476. https://doi.org/10.1021/acs.jmedchem.2c01233
Vancouver
Xiang H, Liu R, Zhang X, An R, Zhou M, Tan C, et al. Discovery of Small-Molecule Autophagy Inhibitors by Disrupting the Protein–Protein Interactions Involving Autophagy-Related 5. Journal of Medicinal Chemistry. 2023;66(4):2457-2476. doi:10.1021/acs.jmedchem.2c01233
BibTeX
@article{Xiang2023,
author = {Xiang, Honggang and Liu, Ruiqi and Zhang, Xiangying and An, Ran and Zhou, Mi and Tan, Chang and Li, Qing and Su, Minyi and Guo, Chun and Zhou, Lu and Li, Yingxia and Wang, Renxiao},
title = {Discovery of Small-Molecule Autophagy Inhibitors by Disrupting the Protein–Protein Interactions Involving Autophagy-Related 5},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {4},
pages = {2457--2476},
doi = {10.1021/acs.jmedchem.2c01233}
}
EUVIMED